Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab

Lignende værker

• A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages
  af: Watanabe, Hiromi, et al.
  Udgivet: (2019)
• Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction
  af: Nishii, Kazuya, et al.
  Udgivet: (2020)
• Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (EGFR) Mutation with a History of Acquired Resistance to Osimertinib
  af: Makimoto, Go, et al.
  Udgivet: (2019)
• Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression
  af: Nishii, Kazuya, et al.
  Udgivet: (2021)
• VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers
  af: Watanabe, Hiromi, et al.
  Udgivet: (2021)